Table 3.
Variable | Group | Baseline | End of Study | P-value# |
---|---|---|---|---|
Fat (0-3) | Control | 1.9 (0.9) | 1.6 (1.0) | 0.02 |
LS | 1.9 (0.7) | 0.8 (0.9) | ||
Parenchymal Inflammation (0-3) |
Control | 1.7 (0.8) | 1.3 (0.8) | 0.18 |
LS | 1.4 (0.6) | 0.9 (0.5) | ||
Ballooning Injury (0-2) |
Control | 1.3 (0.5) | 0.6 (0.7) | 0.22 |
LS | 1.2 (0.5) | 0.3 (0.6) | ||
Fibrosis (0-4) | Control | 1.7 (0.8) | 1.4 (1.3) | 0.62 |
LS | 1.4 (1.1) | 1.4 (1.0) | ||
NAS (0-8) | Control | 4.9 (1.0) | 3.5 (1.8) | 0.05 |
LS | 4.4 (1.1) | 2.0 (1.5) |
Control group, N=10, LS group, N=18
Data expressed as mean (SD)
P-value compares the mean difference between the pre- and post-treatment changes in the variables between the two groups.